BackCancer Genetics Overview

Cancer Genetics Other Liabilities

Cancer Genetics's other liabilities is $110K.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$105000.00

Peer average

Loading

Cancer Genetics Other Liabilities History

Loading

Cancer Genetics vs. peers: Other Liabilities Comparison

Loading

Cancer Genetics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cancer Genetics (CGIX) FAQ

As of the most recent data (December 2020), CGIX shows a other liabilities of $110K. Scroll down for historical charts and peer comparison views.

Tracking CGIX's other liabilities over time shows whether Cancer Genetics is scaling, shrinking, or reshaping that part of the business. The current reading is $110K Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Cancer Genetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $110K) with ownership activity and broader fundamentals.

Cancer Genetics's other liabilities is $110K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.